Table 1 Clinicopathological characteristics of patients
Patient characteristics | Number of patients (n = 44) | Percentage |
|---|---|---|
Age | ||
≤ 66 years | 24 | 54.5 |
> 66 years | 20 | 45.5 |
Sex | ||
Male | 27 | 61.4 |
Female | 17 | 38.6 |
Stage | ||
IV | 44 | 100 |
ECOG | ||
0 | 12 | 27.2 |
1 | 23 | 52.3 |
2 | 8 | 18.2 |
3 | 1 | 2.3 |
Primary tumor location | ||
Body | 19 | 43.2 |
Tail | 12 | 27.3 |
Head | 13 | 29.5 |
First-line treatment | ||
Gemcitabine/ ± nab-paclitaxel | 37 | 84.1 |
FOLFIRINOX | 4 | 9.1 |
No treatment | 3 | 6.8 |
Number of metastatic lesions | ||
One | 24 | 54.6 |
More than one | 20 | 45.4 |
Metastatic lesions location | ||
Hepatic | 36 | 81.8 |
Non-hepatic | 8 | 18.2 |
Tissue Biopsy RAS statusa | ||
RAS mutated | 20 | 69 |
RAS wild-type | 9 | 31 |
Liquid Biopsy RAS status | ||
RAS mutated | 35 | 79.5 |
RAS wild-type | 9 | 20.5 |